Szebeni J
Department of Membrane Biochemistry, Walter Reed Army Institute of Research, Washington, D.C. 20307-5100, USA.
Crit Rev Ther Drug Carrier Syst. 1998;15(1):57-88.
Activation of complement (C) by haptenized liposomes has been utilized for a long time to study the interaction of biological membranes with C proteins, or as a sensitive immunoassay for the measurement of specific antigens, antibodies, or serum hemolytic C levels. However, it has been increasingly recognized that regardless of antigenicity, C activation is an intrinsic property of all charged phospholipid/cholesterol bilayers. Liposome-induced C activation and its biological consequences show significant interspecies and interindividual variation, and critically depend on the properties of vesicles as well. Activation can proceed through both the classical and the alternative pathways, with or without the involvement of antibodies. The practical significance of the phenomenon is twofold: 1) opsonization of the vesicles promotes their clearance from the circulation and 2) the liberation of C3a and C5a can cause numerous, potentially adverse, biological reactions. In fact, many cardiovascular and hematological changes observed following administration of liposomes in vivo can be explained by C activation; a fact that has not yet gained wide recognition in the field of drug-carrier liposomes.
长期以来,已利用半抗原化脂质体激活补体(C)来研究生物膜与补体蛋白的相互作用,或作为一种灵敏的免疫测定法来测量特定抗原、抗体或血清溶血补体水平。然而,人们越来越认识到,无论抗原性如何,补体激活是所有带电磷脂/胆固醇双层膜的固有特性。脂质体诱导的补体激活及其生物学后果表现出显著的种间和个体间差异,并且也严重依赖于囊泡的性质。激活可通过经典途径和替代途径进行,无论是否有抗体参与。该现象的实际意义有两方面:1)囊泡的调理作用促进其从循环中清除;2)C3a和C5a的释放可引发众多潜在的不良生物学反应。事实上,体内给予脂质体后观察到的许多心血管和血液学变化都可以用补体激活来解释;这一事实在药物载体脂质体领域尚未得到广泛认可。